Re: Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

Steven A. Kaplan

doi:10.1016/j.juro.2012.01.087

Re: Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

Steven A. Kaplan

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1758-1759
Number of pages	2
Journal	Journal of Urology
Volume	187
Issue number	5
DOIs	https://doi.org/10.1016/j.juro.2012.01.087
State	Published - May 2012

Access to Document

10.1016/j.juro.2012.01.087

Cite this

@article{7695f48345b34ecc8ce02f9540d43c5f,

title = "Re: Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia",

author = "Kaplan, \{Steven A.\}",

year = "2012",

month = may,

doi = "10.1016/j.juro.2012.01.087",

language = "English",

volume = "187",

pages = "1758--1759",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "5",

}

TY - JOUR

T1 - Re

T2 - Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

AU - Kaplan, Steven A.

PY - 2012/5

Y1 - 2012/5

UR - https://www.scopus.com/pages/publications/84859517974

U2 - 10.1016/j.juro.2012.01.087

DO - 10.1016/j.juro.2012.01.087

M3 - Comment/debate

AN - SCOPUS:84859517974

SN - 0022-5347

VL - 187

SP - 1758

EP - 1759

JO - Journal of Urology

JF - Journal of Urology

IS - 5

ER -